MASHINIi

Ventyx Biosciences, Inc..

VTYX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral small molecule therapeutics for autoimmune and inflammatory diseases. Their pipeline includes programs targeting various immunological pathways, aiming to address unmet medical needs...Show More

Ethical Profile

Mixed.

Ventyx Biosciences, a clinical-stage biopharmaceutical company, focuses on developing oral therapies for serious conditions like Crohn's disease, ulcerative colitis, Parkinson's disease, and cryopyrin-associated periodic syndrome. This core mission is fundamentally supportive of improving global health outcomes. However, as is standard practice in biopharmaceutical development, the pursuit of novel therapies may involve animal testing, which critics point to as a tension with animal welfare principles. For other ethical areas, reports suggest insufficient public information is available to provide a comprehensive assessment of Ventyx's practices.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals-50
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Ventyx Biosciences, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company.

1
The provided articles detail its drug pipeline and clinical trial data. None of the articles contain any information related to financial services, lending, insurance, or economic opportunity initiatives.
2
Therefore, no evidence could be found to assess the company against the KPIs for Fair Money & Economic Opportunity, which are designed for financial institutions.

Fair Pay & Worker Respect

0

No evidence available to assess Ventyx Biosciences, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

The provided articles, which are financial reports, do not contain any information regarding the company's fair trade and ethical sourcing practices.

1
Specifically, there is no data available on the percentage of tier-1 spend covered by fair-trade certifications, the frequency of supplier audits, any substantiated forced or child labor incidents, the traceability coverage of the supply chain, the median days to close corrective action plans, the coverage of ethical-sourcing clauses in supplier contracts, the share of spend on high-risk materials, or the procurement budget directed to diverse suppliers.
2

Honest & Fair Business

0

No evidence available to assess Ventyx Biosciences, Inc. on Honest & Fair Business.

Kind to Animals

-50

Ventyx Biosciences conducted preclinical studies using murine diet-induced obesity (DIO) models for VTX3232, involving two separate 28-day studies.

1
The company also references multiple animal models for Parkinson's Disease and genetic deletion/knockout animal disease models for TYK2.
2
No information is provided regarding the employment of non-animal testing methods.

No War, No Weapons

0

The provided articles do not contain any specific, concrete data points or facts related to Ventyx Biosciences' involvement in arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other metrics relevant to the "No War, No Weapons" ethical value.

1
Therefore, no KPIs can be scored based on the available evidence.

Planet-Friendly Business

0

The provided articles, a legal filing (Form 8-K) and a financial report (Form 10-K), explicitly state that they do not contain information about any of the environmental and social responsibility metrics relevant to the 'Planet-Friendly Business' value.

1
Consequently, no evidence was found to assess Ventyx Biosciences, Inc. against the specified KPIs.

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles to assess Ventyx Biosciences, Inc. against any of the KPIs for the 'Respect for Cultures & Communities' value.

1
The articles primarily focus on corporate updates, clinical trials, and the company's drug pipeline, without mentioning community engagement, cultural sensitivity, or related initiatives.
2

Safe & Smart Tech

0

No evidence available to assess Ventyx Biosciences, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, concrete evidence was found in the provided articles for any of the Key Performance Indicators related to 'Zero Waste & Sustainable Products'. While Ventyx Biosciences' Code of Business Conduct and Ethics mentions 'Environmental Responsibility,'

1
this is a general statement of intent and does not provide measurable data for any specific KPI. The S&P Global article indicates that the company is assessed on ESG issues,
2
but it does not provide any actual scores or specific data points regarding waste management, product recyclability, or other related initiatives.

Own Ventyx Biosciences, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.